| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 2, Issue 8 401-407, Copyright © 1991 by American Association of Cancer Research
ARTICLES |
A Abdollahi, KA Lord, B Hoffman-Liebermann and DA Liebermann
Department of Biochemistry and Biophysics, University of Pennsylvania, School of Medicine, Philadelphia 19104.
To better understand the immediate early genetic response of myeloid cells to terminal differentiation and growth inhibitory stimuli, we have recently isolated complementary DNA clones of myeloid differentiation primary response (MyD) genes, activated in the absence of protein synthesis in M1 myeloid precursor cells following induction for terminal differentiation and growth arrest by conditioned media of mouse lungs, a potent physiological source of hemopoietic differentiation inducers. In this study, it is shown that one particular MyD complementary DNA clone, expressed highly in normal precursor enriched bone marrow cells, encodes for interferon regulatory factor 1 (IRF-1), a positive transcription factor for expression of the beta-interferon (IFN-beta) gene. Using a clone of M1 cells inducible for terminal differentiation by both interleukin 6 (IL-6) and leukemia inhibitory factor (LIF), two multifunctional cytokines recently identified as physiological inducers of hemopoietic cell differentiation, it has been shown that IRF-1 expression is rapidly induced by IL-6 and LIF in the absence of protein synthesis and is followed by a later increase in the levels of IFN-beta mRNA, observed to be largely dependent on protein synthesis. Also, it is shown that the growth inhibition associated with IL-6 or LIF induced terminal differentiation could be partially abrogated via the use of IRF-1 antisense oligomers or IFN-beta antiserum. Taken together, these findings imply a regulatory cascade, where induction of terminal myeloid differentiation by IL-6 or LIF triggers the immediate early activation of IRF-1, leading to the later induction of IFN-beta, in turn playing an autocrine role in growth inhibition.
This article has been cited by other articles:
 |
|
 |
|
  B. Fritzsching, N. Oberle, E. Pauly, R. Geffers, J. Buer, J. Poschl, P. Krammer, O. Linderkamp, and E. Suri-Payer Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death Blood, November 15, 2006; 108(10): 3371 - 3378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Passioura, A. Dolnikov, S. Shen, and G. Symonds N-Ras-Induced Growth Suppression of Myeloid Cells Is Mediated by IRF-1 Cancer Res., February 1, 2005; 65(3): 797 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Geserick, F. Kaiser, U. Klemm, S. H. E. Kaufmann, and J. Zerrahn Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif Int. Immunol., October 1, 2004; 16(10): 1535 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Xiao, T. Naganawa, E. Obugunde, G. Gronowicz, D. M. Ornitz, J. D. Coffin, and M. M. Hurley Stat1 Controls Postnatal Bone Formation by Regulating Fibroblast Growth Factor Signaling in Osteoblasts J. Biol. Chem., June 25, 2004; 279(26): 27743 - 27752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schmidt, J. Bies, T. Tamura, K. Ozato, and L. Wolff The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15Ink4b in murine myeloid cells Blood, June 1, 2004; 103(11): 4142 - 4149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. MARSILI, A. BORSETTI, M. SGARBANTI, A. L. REMOLI, B. RIDOLFI, E. STELLACCI, B. ENSOLI, and A. BATTISTINI On the Role of Interferon Regulatory Factors in HIV-1 Replication Ann. N.Y. Acad. Sci., December 1, 2003; 1010(1): 29 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Saeki, K. Saeki, and A. Yuo Distinct involvement of cAMP-response element-dependent transcriptions in functional and morphological maturation during retinoid-mediated human myeloid differentiation J. Leukoc. Biol., May 1, 2003; 73(5): 673 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Creus, K. Van Beneden, F. Stevenaert, V. Debacker, J. Plum, and G. Leclercq Developmental and Functional Defects of Thymic and Epidermal V{gamma}3 Cells in IL-15-Deficient and IFN Regulatory Factor-1-Deficient Mice J. Immunol., June 15, 2002; 168(12): 6486 - 6493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sgarbanti, A. Borsetti, N. Moscufo, M. C. Bellocchi, B. Ridolfi, F. Nappi, G. Marsili, G. Marziali, E. M. Coccia, B. Ensoli, et al. Modulation of Human Immunodeficiency Virus 1 Replication by Interferon Regulatory Factors J. Exp. Med., May 20, 2002; 195(10): 1359 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Amanullah, B. Hoffman, and D. A. Liebermann Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15INK4B and p16INK4A Blood, July 15, 2000; 96(2): 475 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Senaldi, C. L. Shaklee, J. Guo, L. Martin, T. Boone, T. W. Mak, and T. R. Ulich Protection Against the Mortality Associated with Disease Models Mediated by TNF and IFN-{gamma} in Mice Lacking IFN Regulatory Factor-1 J. Immunol., December 15, 1999; 163(12): 6820 - 6826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. T. T. Sjin, K. A. Lord, A. Abdollahi, B. Hoffman, and D. A. Liebermann Interleukin-6 and Leukemia Inhibitory Factor Induction of JunB Is Regulated by Distinct Cell Type-specific Cis-acting Elements J. Biol. Chem., October 1, 1999; 274(40): 28697 - 28707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sahni, D.-C. Ambrosetti, A. Mansukhani, R. Gertner, D. Levy, and C. Basilico FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway Genes & Dev., June 1, 1999; 13(11): 1361 - 1366. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z. A. Percario, V. Giandomenico, G. Fiorucci, M. V. Chiantore, S. Vannucchi, J. Hiscott, E. Affabris, and G. Romeo Retinoic Acid Is Able to Induce Interferon Regulatory Factor 1 in Squamous Carcinoma Cells via a STAT-1 Independent Signalling Pathway Cell Growth Differ., April 1, 1999; 10(4): 263 - 270. [Abstract] [Full Text]
|
|
|
|
|
|
J. Pizarro-Cerda, M. Desjardins, E. Moreno, S. Akira, and J.-P. Gorvel Modulation of Endocytosis in Nuclear Factor IL-6(-/-) Macrophages Is Responsible for a High Susceptibility to Intracellular Bacterial Infection J. Immunol., March 15, 1999; 162(6): 3519 - 3526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. JACKSON, S. E. M. HOWIE, R. WELLER, E. SABIN, J. A. A. HUNTER, and R. C. McKENZIE Psoriatic keratinocytes show reduced IRF-1 and STAT-1{alpha} activation in response to {gamma}-IFN FASEB J, March 1, 1999; 13(3): 495 - 502. [Abstract] [Full Text]
|
|
|
|
|
|
K. Krishnaraju, B. Hoffman, and D. A. Liebermann The Zinc Finger Transcription Factor Egr-1 Activates Macrophage Differentiation in M1 Myeloblastic Leukemia Cells Blood, September 15, 1998; 92(6): 1957 - 1966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Krishnaraju, B. Hoffman, and D. A. Liebermann Lineage-Specific Regulation of Hematopoiesis by HOX-B8 (HOX-2.4): Inhibition of Granulocytic Differentiation and Potentiation of Monocytic Differentiation Blood, September 1, 1997; 90(5): 1840 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brakebusch, B. Jallal, O. Fusco, S. Iacobelli, and A. Ullrich Expression of the 90K Immunostimulator Gene Is Controlled by a Promoter with Unique Features J. Biol. Chem., February 7, 1997; 272(6): 3674 - 3682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Luo and D. G. Skalnik Interferon Regulatory Factor-2 Directs Transcription from the gp91phox Promoter J. Biol. Chem., September 20, 1996; 271(38): 23445 - 23451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Kimura, K Nakayama, J Penninger, M Kitagawa, H Harada, T Matsuyama, N Tanaka, R Kamijo, J Vilcek, T. Mak, et al. Involvement of the IRF-1 transcription factor in antiviral responses to interferons Science, June 24, 1994; 264(5167): 1921 - 1924. [Abstract] [PDF]
|
|
|
|
|
|
R Kamijo, H Harada, T Matsuyama, M Bosland, J Gerecitano, D Shapiro, J Le, S. Koh, T Kimura, S. Green, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages Science, March 18, 1994; 263(5153): 1612 - 1615. [Abstract] [PDF]
|
|
|
|
|
|
C. Willman, C. Sever, M. Pallavicini, H Harada, N Tanaka, M. Slovak, H Yamamoto, K Harada, T. Meeker, A. List, et al. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia Science, February 12, 1993; 259(5097): 968 - 971. [Abstract]
|
|
|
|
|
|
H Harada, M Kitagawa, N Tanaka, H Yamamoto, K Harada, M Ishihara, and T Taniguchi Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 Science, February 12, 1993; 259(5097): 971 - 974. [Abstract]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
